Need answers? 1·800·227·2345 | Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Making Treatment Decisions
 
    Types of Treatment
    Clinical Trials
    Treatment Decision Tools
    Choosing Treatment Facilities and Health Professionals
    Find Treatment Centers
    Nutrition for Cancer Patients
    Staying Active During Treatment
    Complementary & Alternative Therapies
    Guide to Cancer Drugs
    Talking About Cancer
    Message Boards
Glossary
    I Want to Help
  You can help in the fight against cancer. Donate and volunteer.
  Learn more
   
Alternatives To Blood Transfusion

Because blood transfusions carry risks and because the blood supply is limited, doctors try not to transfuse when possible. In some cases, options other than blood product transfusions may be available.

Volume expanders: When a patient has lost a lot of body fluids but does not need red blood cells or other blood cells, shock may be treated or prevented by solutions to keep the circulation going. The most common solutions are normal saline (sterile water with a precise amount of salt) and lactated Ringer's solution (saline plus other chemicals). Other such solutions (called volume expanders) include albumin, hydroxyethyl starch (HES), dextrans, and purified protein fractions. All of these increase volume, but do not change the number of blood cells.

Growth factors: As described in the section "Why cancer patients might need blood product transfusions," the body naturally makes hormone-like substances called hematopoietic growth factors that cause the bone marrow to make more blood cells. Scientists have learned how to make some of these growth factors in the lab to help people with low blood cell counts. Growth factors can be used to boost red blood cell, white blood cell, or platelet counts.

Growth factors may help patients who would otherwise need transfusions. But they have some drawbacks that may limit their use in some cases:

  • Unlike transfusions, growth factors often take many days or even weeks to raise blood counts, so they may not be useful in people who need blood cell levels raised quickly, such as those with active bleeding.
  • People who have severe bone marrow disease may not respond to the growth factors because they do not have enough blood-producing cells in their bone marrow.
  • Some growth factors might cause certain types of cancer cells (such as lymphocytic leukemia, multiple myeloma, head and neck cancer, breast cancer, cervical cancer, and some kinds of lung cancer cells) to grow more quickly.
  • Growth factors generally cost a lot more than transfusions.

Because of these drawbacks, certain growth factors are not used in people whose treatment is expected to cure their cancer. And when they are used, they are given for as short a time as possible.

Intra-operative or post-operative blood salvage: Patients getting surgery sometimes need transfusions to replace the blood lost during or after the operation. In some cases this lost blood can be "salvaged" or saved by collecting it with a special machine and giving it back into the patient. Giving a person back his or her own (autologous) blood cuts down on the need for transfusions from other donors. (Another type of autologous transfusion is described in the "Blood donation" section.)

Blood substitutes: So far, there is no real substitute for human blood. But researchers are working to develop a liquid that can carry oxygen and replace blood, at least for a short time, in certain situations. Products that are being tested include hemoglobin-based oxygen carriers and perfluorochemical compounds. They can do some of the work of red blood cells, such as carrying oxygen to tissues, but cannot replace the many functions that human blood does. Of the oxygen-carrying compounds that are being tested in U.S. clinical trials, none has been approved by the FDA as of 2009.

Most blood substitutes are experimental and are rarely used. They may be used as a short-term measure in patients whose religious beliefs do not allow them to have blood product transfusions. They may also help patients with rare blood types and those whose immune systems would destroy donated blood. The substitutes may be used until matching donated blood can be found, which in some cases might take several days.

Last Medical Review: 07/13/2009
Last Revised: 07/13/2009

Printer-Friendly Page
Email this Page
Related Tools & Topics
Learn About Cancer  
Treatment Topics and Resources  
Building a Support Network  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2010 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.